Literature DB >> 14619953

Structure and evolutionary aspects of matrix metalloproteinases: a brief overview.

Sudip Das1, Malay Mandal, Tapati Chakraborti, Amritlal Mandal, Sajal Chakraborti.   

Abstract

The matrix metalloproteinases (MMPs) are zinc dependent endopeptidases known for their ability to cleave one or several extracellular matrix (ECM) constituents, as well as non-matrix proteins. They comprise a large family of proteinases that share common structural and functional elements and are products of different genes. All members of this family contain a signal peptide, a propeptide and a catalytic domain. The catalytic domain contains two zinc ions and at least one calcium ion coordinated to various residues. All MMPs, with the exception matrilysin, have a hemopexin/vitronectin-like domain that is connected to the catalytic domain by a hinge or linker region. The hemopexin-like domain influences tissue inhibitor of metalloproteinases (TIMP) binding, the binding of certain substrates, membrane activation, and some proteolytic activities. It has been proposed that the origin of MMPs could be traced to before the emergence of vertebrates from invertebrates. It appears conceivable that the domain assemblies occurred at an early stage of the diversification of different MMPs and that they progressed through the evolutionary process independent of one another, and perhaps parallel to each other.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619953     DOI: 10.1023/a:1026093016148

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  67 in total

Review 1.  Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.

Authors:  P Borden; R A Heller
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1997       Impact factor: 1.807

2.  Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme.

Authors:  S P Salowe; A I Marcy; G C Cuca; C K Smith; I E Kopka; W K Hagmann; J D Hermes
Journal:  Biochemistry       Date:  1992-05-19       Impact factor: 3.162

3.  Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity.

Authors:  J M Maidment; D Moore; G P Murphy; G Murphy; I M Clark
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

4.  Structure of human neutrophil collagenase reveals large S1' specificity pocket.

Authors:  T Stams; J C Spurlino; D L Smith; R C Wahl; T F Ho; M W Qoronfleh; T M Banks; B Rubin
Journal:  Nat Struct Biol       Date:  1994-02

5.  A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development.

Authors:  M Yang; M T Murray; M Kurkinen
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

Review 6.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

7.  Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development.

Authors:  E Llano; A M Pendás; P Aza-Blanc; T B Kornberg; C López-Otín
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

8.  Early expression of a collagenase-like hatching enzyme gene in the sea urchin embryo.

Authors:  T Lepage; C Gache
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

9.  Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1).

Authors:  L C Chen; M E Noelken; H Nagase
Journal:  Biochemistry       Date:  1993-10-05       Impact factor: 3.162

10.  The NMR structure of the inhibited catalytic domain of human stromelysin-1.

Authors:  P R Gooley; J F O'Connell; A I Marcy; G C Cuca; S P Salowe; B L Bush; J D Hermes; C K Esser; W K Hagmann; J P Springer
Journal:  Nat Struct Biol       Date:  1994-02
View more
  14 in total

1.  Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.

Authors:  Akhilesh Kumar; Shephali Bhatnagar; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8.

Authors:  Sukesh Kalva; D Vinod; Lilly M Saleena
Journal:  J Mol Model       Date:  2014-04-23       Impact factor: 1.810

3.  A novel mechanism of latency in matrix metalloproteinases.

Authors:  Mar López-Pelegrín; Miroslaw Ksiazek; Abdulkarim Y Karim; Tibisay Guevara; Joan L Arolas; Jan Potempa; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

4.  Molecular chaperone function for myocilin.

Authors:  Ann Marie Anderssohn; Kalani Cox; Kevin O'Malley; Scott Dees; Mojgan Hosseini; Lacey Boren; Anthony Wagner; John M Bradley; Mary J Kelley; Ted S Acott
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

5.  New β-Propellers Are Continuously Amplified From Single Blades in all Major Lineages of the β-Propeller Superfamily.

Authors:  Joana Pereira; Andrei N Lupas
Journal:  Front Mol Biosci       Date:  2022-06-09

6.  Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.

Authors:  Hong Li; Ashwani Mittal; Pradyut K Paul; Mukesh Kumar; Daya S Srivastava; Suresh C Tyagi; Ashok Kumar
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

7.  The molecular mechanism of hypertrophic scar.

Authors:  Zhensen Zhu; Jie Ding; Heather A Shankowsky; Edward E Tredget
Journal:  J Cell Commun Signal       Date:  2013-03-18       Impact factor: 5.782

8.  Curcumin suppresses gelatinase B mediated norepinephrine induced stress in H9c2 cardiomyocytes.

Authors:  Shrey Kohli; Aastha Chhabra; Astha Jaiswal; Yashika Rustagi; Manish Sharma; Vibha Rani
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 9.  Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.

Authors:  Yuji Ogura; Marjan M Tajrishi; Shuichi Sato; Sajedah M Hindi; Ashok Kumar
Journal:  Front Cell Dev Biol       Date:  2014-04-01

Review 10.  The significance of matrix metalloproteinases in parasitic infections involving the central nervous system.

Authors:  Fabrizio Bruschi; Barbara Pinto
Journal:  Pathogens       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.